107 related articles for article (PubMed ID: 19881252)
1. Distribution characteristics of telithromycin, a novel ketolide antimicrobial agent applied for treatment of respiratory infection, in lung epithelial lining fluid and alveolar macrophages.
Togami K; Chono S; Seki T; Morimoto K
Drug Metab Pharmacokinet; 2009; 24(5):411-7. PubMed ID: 19881252
[TBL] [Abstract][Full Text] [Related]
2. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
Togami K; Chono S; Morimoto K
Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
[TBL] [Abstract][Full Text] [Related]
3. Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Seki T; Morimoto K
Drug Dev Ind Pharm; 2010 Jul; 36(7):861-6. PubMed ID: 20515406
[TBL] [Abstract][Full Text] [Related]
4. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells.
Togami K; Chono S; Morimoto K
Pharmazie; 2012 May; 67(5):389-93. PubMed ID: 22764569
[TBL] [Abstract][Full Text] [Related]
5. Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae.
Ong CT; Dandekar PK; Sutherland C; Nightingale CH; Nicolau DP
Chemotherapy; 2005 Oct; 51(6):339-46. PubMed ID: 16224186
[TBL] [Abstract][Full Text] [Related]
6. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
7. Intracellular pharmacokinetics of telithromycin, a ketolide antibiotic, in alveolar macrophages.
Togami K; Chono S; Seki T; Morimoto K
J Pharm Pharmacol; 2010 Jan; 62(1):71-5. PubMed ID: 20723001
[TBL] [Abstract][Full Text] [Related]
8. Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).
Muller-Serieys C; Soler P; Cantalloube C; Lemaitre F; Gia HP; Brunner F; Andremont A
Antimicrob Agents Chemother; 2001 Nov; 45(11):3104-8. PubMed ID: 11600363
[TBL] [Abstract][Full Text] [Related]
9. Involvement of intestinal permeability in the oral absorption of clarithromycin and telithromycin.
Togami K; Hayashi Y; Chono S; Morimoto K
Biopharm Drug Dispos; 2014 Sep; 35(6):321-9. PubMed ID: 24801141
[TBL] [Abstract][Full Text] [Related]
10. [Intrapulmonary Pharmacokinetics and Drug Distribution Characteristics for the Treatment of Respiratory Diseases].
Togami K
Yakugaku Zasshi; 2020; 140(3):345-354. PubMed ID: 32115551
[TBL] [Abstract][Full Text] [Related]
11. Intrapulmonary pharmacokinetics of telithromycin, a new ketolide, in healthy Japanese volunteers.
Kadota J; Ishimatsu Y; Iwashita T; Matsubara Y; Tomono K; Tateno M; Ishihara R; Muller-Serieys C; Kohno S
Antimicrob Agents Chemother; 2002 Mar; 46(3):917-21. PubMed ID: 11850288
[TBL] [Abstract][Full Text] [Related]
12. [Designs of optimized microbial therapy systems of respiratory infections].
Morimoto K
Yakugaku Zasshi; 2013; 133(1):81-92. PubMed ID: 23292024
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic efficacy of intrapulmonary administration of ciprofloxacin for the treatment of respiratory infections.
Chono S; Tanino T; Seki T; Morimoto K
Drug Metab Pharmacokinet; 2007 Apr; 22(2):88-95. PubMed ID: 17495415
[TBL] [Abstract][Full Text] [Related]
14. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Pulm Pharmacol Ther; 2007; 20(5):549-55. PubMed ID: 17127087
[TBL] [Abstract][Full Text] [Related]
16. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.
Hawkins EC; Boothe DM; Guinn A; Aucoin DP; Ngyuen J
J Vet Pharmacol Ther; 1998 Feb; 21(1):18-23. PubMed ID: 9507453
[TBL] [Abstract][Full Text] [Related]
17. Subcellular distribution of azithromycin and clarithromycin in rat alveolar macrophages (NR8383) in vitro.
Togami K; Chono S; Morimoto K
Biol Pharm Bull; 2013; 36(9):1494-9. PubMed ID: 23995662
[TBL] [Abstract][Full Text] [Related]
18. Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation.
Leiva M; Ruiz-Bravo A; Jimenez-Valera M
Chest; 2008 Jul; 134(1):20-9. PubMed ID: 18403658
[TBL] [Abstract][Full Text] [Related]
19. Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces.
Kaneko K; Togami K; Yamamoto E; Wang S; Morimoto K; Itagaki S; Chono S
Drug Deliv Transl Res; 2016 Oct; 6(5):565-71. PubMed ID: 27334278
[TBL] [Abstract][Full Text] [Related]
20. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
